Avelumab (Anti-Human PD-L1) a fully human IgG1 anti-PD-L1 monoclonal antibody (mAb) with potential antibody-dependent cell-mediated cytotoxicity (ADCC) . Avelumab enhances ADCC on several cancer cell lines expressing PD-L1. Avelumab can be used for the study of chordoma[1].
CAS Number
[1537032-82-8]
Smiles
[Avelumab]
Target
PD-1/PD-L1
Purity
99.3
Solubility
H2O
Storage Conditions
Store at 4°C for 2 years, do not freeze
Shipping Conditions
Isolate blue ice and the product with bubble pack to avoid direct contact